| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967067 | Vaccine | 2013 | 9 Pages |
Abstract
Severe attenuation and favorable immune responses following administration of a first generation Pf p52â/p36â GAP suggests that further development of live-attenuated strains using genetic engineering should be pursued.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michele Spring, Jittawadee Murphy, Robin Nielsen, Megan Dowler, Jason W. Bennett, Stasya Zarling, Jack Williams, Patricia de la Vega, Lisa Ware, Jack Komisar, Mark Polhemus, Thomas L. Richie, Judy Epstein, Cindy Tamminga, Ilin Chuang, Nancy Richie,